pubmed-article:12490799 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:12490799 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:12490799 | lifeskim:mentions | umls-concept:C0221912 | lld:lifeskim |
pubmed-article:12490799 | lifeskim:mentions | umls-concept:C0018133 | lld:lifeskim |
pubmed-article:12490799 | lifeskim:mentions | umls-concept:C0031765 | lld:lifeskim |
pubmed-article:12490799 | pubmed:issue | 11 | lld:pubmed |
pubmed-article:12490799 | pubmed:dateCreated | 2002-12-19 | lld:pubmed |
pubmed-article:12490799 | pubmed:abstractText | Graft versus host disease (GVHD) is an important problem following allogenic bone marrow transplantation (BMT). The beneficial effects of photochemotherapy with psoralens plus UVA irradiation (PUVA) have been described repeatedly; however, PUVA is limited by a wide range of unwanted effects. A novel improved form of UV-B phototherapy, narrowband UV-B, has been proven to be very effective in T-cell mediated dermatoses. Therefore, we investigated the effect of narrowband UV-B phototherapy (5 times per week) in 10 patients with cutaneous GVHD (grade 2-3) resistant to standard immunosuppressive drugs. It was tolerated well by all patients, and no side effects were observed. Skin lesions showed complete clearance in 7 out of 10 patients within 3 to 5 weeks. 3 patients showed significant improvement of GVHD. We suggest that narrowband UV-B phototherapy is a nonaggressive treatment that may benefit patients with cutaneous GVHD who already take high doses of immunosuppressive drugs. | lld:pubmed |
pubmed-article:12490799 | pubmed:language | eng | lld:pubmed |
pubmed-article:12490799 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12490799 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:12490799 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12490799 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:12490799 | pubmed:month | Dec | lld:pubmed |
pubmed-article:12490799 | pubmed:issn | 0041-1337 | lld:pubmed |
pubmed-article:12490799 | pubmed:author | pubmed-author:HoelzerDieter... | lld:pubmed |
pubmed-article:12490799 | pubmed:author | pubmed-author:KaufmannRolan... | lld:pubmed |
pubmed-article:12490799 | pubmed:author | pubmed-author:BoehnckeWolf-... | lld:pubmed |
pubmed-article:12490799 | pubmed:author | pubmed-author:KleinStefanS | lld:pubmed |
pubmed-article:12490799 | pubmed:author | pubmed-author:PoddaMaurizio... | lld:pubmed |
pubmed-article:12490799 | pubmed:author | pubmed-author:MartinHansH | lld:pubmed |
pubmed-article:12490799 | pubmed:author | pubmed-author:Grundmann-Kol... | lld:pubmed |
pubmed-article:12490799 | pubmed:author | pubmed-author:LudwigRalfR | lld:pubmed |
pubmed-article:12490799 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:12490799 | pubmed:day | 15 | lld:pubmed |
pubmed-article:12490799 | pubmed:volume | 74 | lld:pubmed |
pubmed-article:12490799 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:12490799 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:12490799 | pubmed:pagination | 1631-4 | lld:pubmed |
pubmed-article:12490799 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
pubmed-article:12490799 | pubmed:meshHeading | pubmed-meshheading:12490799... | lld:pubmed |
pubmed-article:12490799 | pubmed:meshHeading | pubmed-meshheading:12490799... | lld:pubmed |
pubmed-article:12490799 | pubmed:meshHeading | pubmed-meshheading:12490799... | lld:pubmed |
pubmed-article:12490799 | pubmed:meshHeading | pubmed-meshheading:12490799... | lld:pubmed |
pubmed-article:12490799 | pubmed:meshHeading | pubmed-meshheading:12490799... | lld:pubmed |
pubmed-article:12490799 | pubmed:meshHeading | pubmed-meshheading:12490799... | lld:pubmed |
pubmed-article:12490799 | pubmed:meshHeading | pubmed-meshheading:12490799... | lld:pubmed |
pubmed-article:12490799 | pubmed:meshHeading | pubmed-meshheading:12490799... | lld:pubmed |
pubmed-article:12490799 | pubmed:meshHeading | pubmed-meshheading:12490799... | lld:pubmed |
pubmed-article:12490799 | pubmed:meshHeading | pubmed-meshheading:12490799... | lld:pubmed |
pubmed-article:12490799 | pubmed:meshHeading | pubmed-meshheading:12490799... | lld:pubmed |
pubmed-article:12490799 | pubmed:year | 2002 | lld:pubmed |
pubmed-article:12490799 | pubmed:articleTitle | Narrowband UV-B phototherapy in the treatment of cutaneous graft versus host disease. | lld:pubmed |
pubmed-article:12490799 | pubmed:affiliation | Department of Dermatology, Johann Wolfgang Goethe University, Theodor Stern Kai 7, 60590 Frankfurt, Germany. | lld:pubmed |
pubmed-article:12490799 | pubmed:publicationType | Journal Article | lld:pubmed |